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Atopic dermatitis, a common, chronic, in¯amma-
tory skin disease that occurs with increasing preva-
lence, is characterized by hyperactivated cytokines of
helper T cell subset 2 and is frequently associated
with staphylococcal infection. An experimental ani-
mal model of atopic dermatitis induced by transge-
nically introduced cytokine is not available. We
generated a transgenic mouse line expressing epider-
mal interleukin-4, a critical cytokine of helper T cell
subset 2. Here we show that transgenic mice spon-
taneously developed a pruritic in¯ammatory skin dis-
ease reproducing all key features of human atopic
dermatitis, including xerosis, conjunctivitis, in¯am-
matory skin lesions, Staphylococcus aureus infection,
histopathology of chronic dermatitis with T cell,
mast cell, macrophage-like mononuclear cell, and
eosinophil in®ltration, and elevation of total serum
IgE and IgG1. The onset and early progression of
skin disease coincided with increased total serum IgE
and IgG1. The mouse disease occurred at a 43%
annual incidence rate and primarily affected the
poorly haired skin: ear (100%), neck (65%), eye
(53%), face (29%), tail (12%), leg (12%), and torso
(6%). As a group the affected transgenic mice mani-
fested with a skin disorder that ful®lled the clinical
diagnostic criteria established for atopic dermatitis in
human patients. Pending further characterization to
authenticate it as a model of atopic dermatitis, this
experimental animal model of pruritic in¯ammatory
skin disease may facilitate investigations for the
roles of interleukin-4 in cutaneous in¯ammation and
skin infection in human patients. Key words: IgE/mast
cell/eosinophil/T cell/staphylococcus. J Invest Dermatol
117:977±983, 2001
A
topic dermatitis (AD) is a common, chronic, in¯am-
matory, pruritic (itchy) skin disease that affects a large
population of people and is the most common skin
disease affecting children younger than 11 y of age
(Hani®n and Rajka, 1980; Leung et al, 1999). The
onset of AD is usually in childhood, but 70% of severe cases of AD
will carry forward to adulthood (Arikian et al, 1998). Although not
life-threatening, AD has signi®cant impact on patients' quality of
life and the national economy, with the national medical costs for
AD care estimated to be 360 million dollars in 1990 (Arikian et al,
1998; O'Hare and Krowchuk, 1998). Over the last four decades,
AD has occurred with increasing prevalence among school children
in the developed countries, from about 7% in the 1970s to 20% in
the 1990s (Leung et al, 1999).
The de®nite etiology of AD is not yet determined and multiple
pathogenic factors have been implicated. These factors include
hyperactivation of T helper cell subset 2 (Th2) immune response
(Paul and Seder, 1994; Leung et al, 1999), autoimmunity (Valenta et
al, 1998), infection (Arikian et al, 1998; Hofer et al, 1999; Leung et
al, 1999), allergens (Mudde et al, 1990; Leung et al, 1999), and
genetics (Kawashima et al, 1998; Leung et al, 1999). The most
recent work has focused on the immune etiology. Furthermore,
controversies still exist regarding the role of the Th2 and Th1
immune system in the pathogenesis of AD, particularly in the
chronic phase of the disease (Grewe et al, 1994; Hamid et al, 1994).
An experimental animal model of AD induced by transgenically
introduced Th-subset-speci®c cytokine, if available, would facili-
tate investigations of the relationship between cytokines and skin
infection, and the step-by-step immunologic sequences of events
before and at disease onset and during disease progression.
Because of the need for such an experimental animal model of
AD, we explore whether an epidermally expressed Th2 cytokine
will affect the cutaneous immune system in such a way that an AD
disease clinical phenotype, along with its associated infection, can
be induced. In particular, we ask the question whether epidermal
expression of interleukin-4 (IL-4), the critical Th2 cytokine (Paul
and Seder, 1994), can induce a clinical phenotype of AD and to
what extent the experimental model recapitulates key features of
human AD. The workability of this approach is supported by
reports that epidermally expressed cytokines alter skin immunology
(Turksen et al, 1992; Carroll et al, 1997). Towards that end,
transgenic (Tg) mice were produced containing the murine IL-4
gene at the basal keratinocytes. Here we report that Tg mice
expressing IL-4 in the skin developed a chronic, in¯ammatory,
pruritic skin disease associated with bacterial infection and that the
mouse disease phenotype is clinically, microbiologically, patho-
logically, and serologically identical to AD in humans and ful®lls
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the clinical diagnostic criteria for AD in human patients. With
further characterization to authenticate it as a model of AD, this
experimental mouse model of pruritic in¯ammatory skin disease
may be helpful for gaining insight on the roles of Th2 cytokines in
cutaneous in¯ammation and in the skin immune defense against
infection.
MATERIALS AND METHODS
Tissue-speci®c IL-4 Tg vector construction A cDNA fragment
containing the entire IL-4 coding region ¯anked by BamH I/Bgl II sites
was generated by polymerase chain reaction (PCR) (Xu et al, 1998) with
a mouse IL-4 cDNA template (American Type Culture Collection,
Rockville, MD) and the following primer pairs: forward primer 5¢-
GGATCCGGATCCCAGAGCTATTGATGGGTCTC-3¢ and reverse
primer 5¢-AGATCTAGATCTGCATGGTGGCTCAGTACTAC-3¢.
The PCR product contains the murine IL-4 sequence corresponding to
nucleotide 45-494, including portions of 5¢- and 3¢-untranslated regions,
start and stop codons, and the entire coding region (Lee et al, 1986). The
PCR product was ligated into a PCR cloning vector (PCR-II,
Invitrogen, San Diego, CA). The following BamH I/Bgl II digestion
yielded the desired fragment with sticky ends. This fragment was
subcloned into BamH-I-linearized pG3Z-K14 vector (originally
constructed and modi®ed by Dr. Elaine Fuchs, Howard Hughes Medical
Institute, University of Chicago) to produce a pK14±IL-4 construct
(Vassar et al, 1989). This construct contains basal keratinocyte (keratin
14) speci®c promoter/enhancer, rabbit b-globin intron, murine IL-4
cDNA, and K14 polyA tail (Fig 1).
Generation of IL-4 Tg mouse line The pK14±IL-4 Tg construct
was linearized by EcoR I/Hind III digestion, gel puri®ed, and then sent
to Jackson Laboratory (Bar Harbor, ME) for microinjection into oocytes
of CByB6 F2 mice. The injected oocytes were implanted in CByB6 F1
pseudopregnant mice. The offspring born from these mice were
examined for the incorporation of IL-4 by southern blot analyses using
genomic DNA extracted from tail clippings and murine IL-4 cDNA as a
probe (Jackson Laboratory). The positive IL-4 Tg mice, con®rmed by a
repeated southern blot analysis, were then mated with non-Tg BALB/
cBy mice (Jackson Laboratory). The mice were housed in conventional
cages, along with their non-Tg littermates, fed with standard mouse
chow and water, and observed without any manipulation.
Analysis of tissue-speci®c IL-4 mRNA expression Biopsies
obtained from normal skin of the IL-4 Tg mice and non-Tg littermates
were immediately placed in RNAlater solution (Ambion, Austin, TX),
stored at 4°C and used within 1 mo. The skin was homogenized in
RNAzol B solution (Tel-Test, Friendswood, TX) and the total RNA
was extracted according to the manufacturer's protocol. DNA
contamination was removed by treating the RNA in RNase-free DNase
I at 37°C for 10 min (5 U per mg RNA; Pharmacia, Milwaukee, WI).
The presence of IL-4 mRNA was examined by a 35-cycled reverse
transcriptase PCR (RT-PCR) (Xu et al, 1998) using 1 mg total RNA
with reverse primer 5¢-CAGTGATGTGGACTTGGACTCATTCAT-
GGTGC-3¢ and forward primer 5¢-CCAGCTAGTTGTCATCCTGC-
TCTTCTTTCTCG-3¢ (Clontech, Palo Alto, CA) and an RT-PCR kit
(Gibco-BRL, Grand Island, NY). This primer pair ampli®es a 357 bp
PCR product corresponding to nucleotide 70-427 (Lee et al, 1986). b-
actin mRNA as a housekeeping gene control was similarly examined
using the following primer pairs: reverse primer 5¢-CTCCTTAATGT-
CACGCACGATTTC-3¢ and forward primer 5¢-GTGGGGCGCCCC-
AGGCACCA-3¢ (Fig 1). To con®rm the nucleotide sequence of the
RT-PCR-ampli®ed IL-4 cDNA fragment, the sequence of the IL-4
fragment ¯anked by the above primer pair was analyzed by a MacVector
program for restriction sites (Oxford Molecular, Campbell, CA). Pst I
(Pharmacia, Milwaukee, WI) and EcoR I (Gibco-BRL) were used as
enzymes that would positively and negatively, respectively, digest the
fragment. The IL-4 cDNA control (Clontech) and l DNA (Pharmacia)
were included as positive DNA controls for the enzymes Pst I and EcoR
I, respectively.
Clinical observation The skin of Tg and non-Tg mice was
examined for texture and in¯ammatory lesions and photographed. The
skin disease severity scores were recorded according to a modi®ed
method (Leung et al, 1990; Matsuda et al, 1997). Pus was obtained in
areas of severe cutaneous infection (all from external ears) for bacterial
culture.
Histopathology Biopsies obtained from normal skin of the IL-4 Tg
mice and non-Tg littermates and skin lesions of the IL-4 Tg mice were
®xed in formalin, embedded in paraf®n, and processed for hematoxylin±
eosin, periodic acid±Schiff, Giemsa, and GramõÂs staining. To quantify the
relative number of in¯ammatory cells, the histologic sections of normal
skin of non-Tg mice and early and late in¯ammatory skin lesions of
affected Tg mice were examined under a high power ®eld (503
objective lens) and the number of in¯ammatory cells were counted and
averaged (®ve ®elds per histology section, ®ve mice in each of the three
groups). Statistical analyses of the in¯ammatory cell types, mononuclear
cells, mast cells, and eosinophils were performed with Internet software
VassarStats at the following website: http://vassar.edu.
Immunopathology Biopsies were obtained from normal skin of the
IL-4 Tg mice and non-Tg littermates and skin lesions of the IL-4 Tg
mice and immediately frozen in OCT compound. Cryosections were
sequentially incubated with rat monoclonal antibody to mouse CD3
(Serotec, Raleigh, NC), followed by ¯uorescein isothiocyanate labeled
goat antirat IgG (Kirkeggard and Perry, Gaithersburg, MD). Cryosections
were also incubated with biotin-labeled monoclonal antimouse CD4 or
CD8 (Serotec), followed by streptavidin-labeled Texas Red (Kirkeggard
and Perry).
Enzyme-linked immunosorbent assay (ELISA) For total serum
IgE levels, microtiter plates were coated with monoclonal rat antimouse
IgE (2 mg per ml, Pharmingen, San Diego, CA), followed by sequential
incubation of serially diluted puri®ed mouse IgE (Pharmingen) or sera
(in duplicate) from the IL-4 Tg and non-Tg mice, biotinylated rat
Figure 1. The pK14±-IL-4 Tg construct and the skin mRNA
expression of the IL-4 Tg mice. The complete pK14±IL-4 Tg
construct contains the PG3Z vector, the K14 promoter, the rabbit b-
globin intron, the murine IL-4 cDNA, and a K14 polyA tail (upper
panel). The skin mRNA expression of the IL-4 Tg mice in comparison
with the non-Tg littermates (lower panel). Total RNA was extracted from
normal skin. RT-PCR was performed with murine IL-4-speci®c primer
pair on total RNA extracted from three Tg mice (lanes 2±7) and two
non-Tg littermates (lanes 8, 9). RT-PCR was performed with the mouse
skin RNA in the presence (lanes 2±4, 8, 9) and absence (lanes 5±7) of
reverse transcriptase. RT-PCR was also performed with b-actin primer
pair on the same amount of RNA from the same Tg mice (lanes 10±12)
and the same non-Tg littermates (lanes 13, 14). Lane 1 is the PCR
product performed with the same IL-4 primer pair on a murine IL-4
cDNA control provided by Clontech. The molecular size standards
included are 100 bp DNA ladders.
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monoclonal antimouse IgE (2 mg per ml, Pharmingen), streptavidin
alkaline phosphatase (1:1000, Pharmingen), and then an alkaline
phosphatase substrate (Bio-Rad, Hercule, CA). Optical density was
measured as absorbance in an Optimax microplate reader at 405 nm
(Molecular Devices, Sunnyvale, CA) (Fig 4). Total serum IgE levels
were calculated using the standard curve generated from the results
obtained with the puri®ed mouse IgE. Similarly, microtiter plates were
coated with monoclonal rat antimouse IgG1 or IgG2a (1:2000 dilution;
Serotec), followed by sequential incubation of serially diluted puri®ed
mouse IgG1 or IgG2a (Sigma, St. Louis, MO) or sera (in duplicate) from
the Tg and non-Tg mice, alkaline-phosphatase-labeled rat antimouse
IgG1 or IgG2a (1:500 dilution, Zymed, South San Francisco, CA), and
then the substrate. Measurement of optical density and calculation of
concentrations were performed as above. For serum IL-4 level, sera from
affected Tg mice and non-Tg littermates were similarly assayed with a
commercially available mouse IL-4 ELISA kit sensitive to 7.8 pg per ml
(the lowest mouse IL-4 standard in the assay recommended by the
manufacturer, R&D Systems, Minneapolis, MN). The expected value of
normal mouse serum IL-4 according to a large number of samples
previously tested is zero (or undetected) (N = 40, Cat. No. M4000,
R&D Systems).
RESULTS
Generation of Tg mice The strategy for the IL-4 Tg construct
is detailed in Fig 1 (upper panel). The IL-4 gene incorporation
successfully occurred in two founder mice (CByB6 strain), one
male and one female, con®rmed by repeated southern blot analyses.
The founders (N = 2) were mated with non-Tg BALB/cBy strain
mice to produce 38 offspring.
The skin expression of IL-4 transgene The skin-speci®c
expression of IL-4 mRNA in Tg mice was determined by RT-
PCR performed on total RNA extracted from normal skin
obtained from the Tg and non-Tg mice. RT-PCR demonstrated
the presence and absence of IL-4 mRNA (a 357 bp product) in the
Tg mice and in the non-Tg littermates, respectively (Fig 1, lower
panel). This 357 bp RT-PCR product comigrated with a PCR
product ¯anked by the same primer pair on a control mouse IL-4
cDNA template. The omission of reverse transcriptase in the
reaction solution totally eliminated the IL-4 expression, ruling out
DNA template contamination (Fig 1). The control b-actin cDNA
was present in equal amounts in the Tg and non-Tg mice total
RNA, con®rming the equal quality and quantity of mRNA present
in total RNA extracted from Tg and non-Tg mouse skin. Pst I
completely digested the 357 bp IL-4 PCR fragments generated
Figure 3. The pathology of affected IL-4 Tg
mice showed dermatitis with in®ltration of
mononuclear cells, mast cells, and
eosinophils. Skin biopsies from a non-Tg
littermate (a, d ) and early skin lesions (b, e, g) and
chronic lesions (c, f, h) of IL-4 Tg mice were
®xed in formalin, embedded in paraf®n, and
processed for hematoxylin±eosin (a±c, h) and
Giemsa (d±g)staining. Arrows indicate eosinophils
(h).Scale bar: 50 mm (a±f ), 10 mm (g, h).
Figure 2. The affected IL-4 Tg mice demonstrate in¯ammatory
skin disease clinically. At the age of 4 mo, a male Tg mouse (a, right
side) developed an in¯ammatory skin lesion clearly visible on the ears,
mouth, and around the eyes. A male non-Tg littermate (a, left side) is
pictured for comparison. At the age of 8 mo, the disease progressed in
the same Tg mouse (b±d ).There was severe dermatitis of the head and
neck with areas of crusting, hair loss, and bacterial pyoderma (d) as well
as destruction of external ears and right eye blindness from corneal and
conjunctival scarring (b, frontal view; d, right lateral view). The tail and
the right hind leg showed dry skin and excoriation (c). Severe bacterial
pyoderma was illustrated in two other affected mice (e, f ). Bacterial
culture documented the growth of Staphylococcus aureus (d, e, f ).
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from both the IL-4 cDNA template control and the total RNA of
the Tg mice into two fragments of expected sizes (76 bp and
281 bp), con®rming the nucleotide sequence of the RT-PCR-
ampli®ed IL-4 cDNA fragment. EcoRI digested l DNA, but did
not digest the mouse IL-4 cDNA fragment as predicted (data not
shown).
Tg mice developed a chronic in¯ammatory skin disorder
and skin infection The skin of the newborn Tg mice was not
affected. At the age of 4 mo, xerosis (dry skin) and in¯ammatory
skin lesions surfaced and the skin lesions appeared to be pruritic (as
evidenced by the constant face rubbing and scratch motions of the
affected mice and the absence of such behavior in the unaffected
mice) (Fig 2a). The skin lesions initially occurred at the mice's ears
and subsequently extended to the neck, mouth, around the eyes,
tail, and legs. Eyelid dermatitis, blepharitis, and conjunctivitis
resulted in corneal and conjunctival scarring (Fig 2b, d). Self-
in¯icted excoriation followed by infection in the skin lesions (as
shown clinically by pustules and crusting) slowly destroyed the
external ears (Fig 2b, d, e). Among the total 40 mice (founders and
their offspring), 17 developed dermatitis within a 12 mo
observation period (from birth to 1 y of age), with an annual
incidence of 43%. None of the non-Tg littermates developed skin
lesions during this period (N = 9). The affected mice included the
female founder and seven of her offspring (six male, one female)
and nine offspring of the male founder (®ve male, four female). The
lesions predominantly affected poorly haired skin: ear (100%), neck
(65%), eye (53%), face (29%), tail (12%), leg (12%), and torso (6%)
(Table I). This distribution is similar to the affected skin location in
canine AD (Willemse, 1986) and a spontaneously arising AD-like
skin lesion in an NC/Nga mouse strain (Matsuda et al, 1997).
Among the 17 Tg mice affected with skin in¯ammation, eight
(47%) developed bacterial pyoderma at the external ear areas; none
of the non-Tg littermates or the Tg mice unaffected with skin
in¯ammation developed pyoderma (Fig 2d±f) (Table I).
In¯ammatory skin lesions preceded the onset of pyoderma in all
cases. Microbiologically, bacterial cultures documented the
presence of Staphylococcus aureus (eight of eight mice) and
Pseudomonas aeruginosa (seven of eight mice) in the pus obtained
from mice affected with bacterial pyoderma. The staphylococcal
infection has been documented to be a common infectious
complication and exacerbating factor in human patients with AD
(Hofer et al, 1999; Leung et al, 1999). Pseudomonas otitis externa is
commonly observed in canine patients affected with AD (Dr.
Thierry Olivry, North Carolina State University College of
Veterinary Medicine, unpublished observation). These skin
manifestations in our IL-4 Tg mice resemble the typical
presentation in human patients with AD (Hani®n and Rajka,
1980; Leung et al, 1999).
The pathology of the Tg mice skin lesions is characterized
by chronic dermatitis, mononuclear cell in®ltration, and
mast cell degranulation In the non-Tg littermates histologic
examination of their skin revealed normal epidermal thickness and
trace mononuclear cells in the dermis (Fig 3a). Histologic
examination of the normal appearing skin from the Tg mice
revealed essentially no pathology (data not shown). In the early
in¯ammatory lesions, the Tg mouse skin demonstrated mild
spongiosis and acanthosis, and a dermal and epidermal in®ltration
of mononuclear cells (Fig 3b). Actively degranulating mast cells in
the dermis, the number ranging from few to moderate to
numerous, were observed by Giemsa staining (Fig 3e, g). In the
chronic in¯ammatory lesions, the Tg mouse skin demonstrated
features of chronic dermatitis, including acanthosis of the epidermis
with mild spongiosis, hyperkeratosis with focal areas of
parakeratosis, and a prominent dermal mononuclear cell
in®ltration (Fig 3c). A number of nondegranulating and
minimally degranulating mast cells were observed in the dermis
by Giemsa staining, ranging from few to numerous (Fig 3f). A
moderate degree of eosinophil in®ltration was also observed in the
dermis of chronic lesions (Fig 3h). A few macrophage-like
mononuclear cells were identi®ed in the dermis of early and
chronic skin lesions. In crusting skin lesions, epidermis was absent
and was replaced by serous materials and numerous neutrophils.
Gram+ cocci in clusters and Gram bacilli were detected. Periodic
acid±Schiff stain detected no fungal elements (data not shown).
These pathologic ®ndings resemble those observed in chronic AD
lesions of human patients (Mihm et al, 1976). The mean number of
in¯ammatory cells (per high power ®eld, 503) in the non-Tg
mouse skin, early Tg mouse lesion, and late Tg mouse lesion,
respectively, were calculated as the following: mononuclear cells,
34 (68.0, SD), 94 (68.6 SD), 138 (656.5 SD); mast cells, 4 (61.6
SD), 22 (65.8 SD), 39 (610.4 SD); eosinophils, 0, 0, 8 (64.3 SD).
The p values calculated by one-tailed t test (independent sample
formula) for comparing the mean number of in¯ammatory cells
between non-Tg mouse skin and early Tg mouse lesion, between
non-Tg mouse skin and late Tg mouse lesion, and between early
and late Tg mouse lesions, respectively, were as follows:
mononuclear cells, <0.0001, <0.0001, <0.0002; mast cells,
<0.0001, <0.0001, <0.0001; eosinophils, not applicable,
<0.0001, <0.0001 (SD, standard deviation).
Table I. Skin lesions distributed primarily in hairless areas
Mice Ear Neck Eye Face Tail Leg Torso Pyoderma
1 + + + ± ± ± ± ±
2 + + + ± ± ± ± +
3 + + ± + + ± + +
4 + + ± ± ± ± ± +
5 + + ± ± ± ± ± ±
6 + ± ± ± ± ± ± ±
7 + ± + ± ± ± ± ±
8 + + + + + + ± +
9 + + ± ± ± ± ± ±
10 + + ± ± ± ± ± +
11 + + + + ± ± ± +
12 + ± + ± ± ± ± ±
13 + ± + ± ± ± ± ±
14 + ± + + ± + ± ±
15 + + ± ± ± ± ± +
16 + ± + + ± ± ± ±
17 + + ± ± ± ± ± +
total percentage 100 65 53 29 12 12 6 47
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Prominent epidermal and dermal in®ltrate of T cells
characterized the early in¯ammatory lesions
Immunopathology studies revealed that in the in¯ammatory
lesions in®ltrating CD3+ T cells were observed in the epidermis
and dermis. In chronic in¯ammatory lesions, CD3+ T cells were
observed in similar amount, but only in the dermis. Rare CD3+ T
cells were observed in the non-Tg mice dermis. In the lesional skin,
both CD4+ and CD8+ T cells were observed in approximately the
same quantity (data not shown).
The elevation of Th2-type immunoglobulins characterizes
the serology of Tg mice and correlates with the onset and
early progression of skin disease ELISA assays determined
that at one time point the total serum IgE and IgG1 levels in most
affected Tg mice were highly elevated compared to non-Tg
littermates (Fig 4a). By contrast, the total serum IgG2a levels in the
Tg mice were slightly reduced. The onset of the skin disease was
associated with a concurrent elevation of IgE and IgG1, but not
IgG2a (Fig 4b). Moreover, the total serum IgE remained at high
levels during further disease progression (Fig 4c). The elevated total
serum IgE levels in our IL-4 Tg mice resemble those observed in
human AD patients (Leung et al, 1999) and in NC/Nga mice with
an AD-like skin lesion (Matsuda et al, 1997). Furthermore, canine
AD is also characterized by an elevation of antigen-speci®c IgE
(Willemse, 1986).
Serum IL-4 levels were undetectable in Tg mice Neither
the Tg mice nor the non-Tg littermates had detectable serum levels
of IL-4.
DISCUSSION
Together, the clinical manifestation, the pathologic and immuno-
pathologic ®ndings, the microbiologic data, and the serum total IgE
levels in our mouse disease model ful®ll the current clinical
diagnostic criteria of AD for human patients (Hani®n and Rajka,
1980). Our model ful®lls three major diagnostic criteria, including
pruritus, chronic dermatitis, and family history of atopy (derma-
titis), and four minor diagnostic criteria including elevated serum
IgE, staphylococcal skin infection, xerosis, and conjunctivitis. Our
model also ful®lls four major diagnostic features for canine AD,
including pruritus, facial involvement, chronic dermatitis, and
positive family history of atopy, and at least one minor diagnostic
feature of staphylococcal skin infection (Willemse, 1986). We will
term this disease model as a ``pruritic in¯ammatory skin disease'',
pending further characterization on the detailed in®ltrating
in¯ammatory cell types, lesional cytokine pro®les, and responses
to immune modulators, in authenticating this model as a mouse
counterpart of human AD.
AD has long been suspected to be a T-cell-mediated disease
associated with a hyperactivated Th2 immune abnormality and a
Th1 immune suppression. Bone marrow donors with atopic disease
can transfer their disease to healthy recipients (Agosti et al, 1988).
IL-4-producing T lymphocytes in AD are frequently observed in
lesional skin and peripheral blood and can be spontaneously
activated; this hyperactivated IL-4 production may be due to an
interaction of altered nuclear protein with the IL-4 promoter
(Chan et al, 1996). This concept is further supported by the
observation that AD is improved by interferon g, a Th1 cytokine
(Leung et al, 1999). The role of Th1 lymphocytes in the
pathogenesis of AD remains unresolved, however (Grewe et al,
1994; Hamid et al, 1994). Our model of pruritic in¯ammatory skin
disease suggests that it is initiated by a Th2 cytokine IL-4 and
provides the opportunity to delineate the role of Th1 cytokines in
the chronic disease phase.
The in¯ammatory skin disease in our model primarily occurred
in poorly haired skin (Table I), similar to the ®ndings observed in
canine AD and a spontaneous mouse AD-like skin disease
(Willemse, 1986; Matsuda et al, 1997). In human patients, AD
primarily involved infants' face, scalp (relatively hairless at that
time), and extensor surfaces, but sparing the diaper area (which is
protected by the diaper from contacting environmental factors)
(Leung et al, 1999), and primarily affected adults' face, antecubital
fossae, and propiteal fossae (Leung et al, 1999). Presumably, hairless
areas have a greater exposure to environmental factors, which may
play roles in the initiation of this in¯ammatory skin disease and AD
and may explain the delayed onset of skin lesions in our model.
Histopathologically, actively degranulating mast cells were
present in the early lesions of our model and these mast cells,
though less active in degranulation, persist in the chronic lesions
(Fig 3). The abundance of serum IgE in our mouse model could be
Figure 4. Total serum IgE and IgG1 concentrations in the
affected IL-4 Tg mice are elevated and coincide with the onset
and early progression of in¯ammatory skin lesions. In (a), total
serum levels of IgE, IgG1, and IgG2a were examined for the affected Tg
mice (D, N = 12) and the non-Tg littermates (s, N = 8) at one time
point. In (b), total serum levels of IgE (D), IgG1 (s), and IgG2a (h) in
relation to the onset of skin disease are illustrated (N = 2). The numbers
on the horizontal axis (not in exact scale) marked by negative (±) signs
represent the days before the onset of skin disease. #3 indicates Tg
mouse #3, #6 indicates Tg mouse #6. In (c), total serum levels of IgE in
relation to the progression of skin disease (as indicated by severity scores)
in seven affected Tg mice are illustrated.
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the source for the mast cell degranulation. Staphylococcal toxins, by
augmenting speci®c IgE responses, could trigger mast cell
degranulation (Hofer et al, 1999; Leung et al, 1999). Through the
known actions of the in¯ammatory mediators in their granules such
as histamines, prostaglandins, leukotrienes, and Th2 cytokines, the
activated mast cells may participate in both the initiation and
maintenance of in¯ammatory lesions. The absence of eosinophils in
the early skin lesions and the moderate presence of eosinophils in
the chronic skin lesions in our mouse model suggest that
eosinophils do not have a signi®cant role in the initiation of this
in¯ammatory disease but may have a role in the maintenance of the
disease. Previously, a minor skin in¯ammation, blepharitis, has been
reported in mice transgenic for IL-4 under the control of nonskin-
speci®c promoter (Tepper et al, 1990). Histologically, these skin
lesions contain dense dermal in®ltrates of mononuclear cells, mast
cells, and eosinophils (Tepper et al, 1990), similar to those observed
in the skin lesions of our skin-speci®c IL-4 Tg mice. Serologically,
these IL-4 Tg mice also had elevated total serum IgE (Tepper et al,
1990), as observed in our IL-4 Tg mice. The reason that these IL-4
Tg mice contained in a pathogen-free facility did not develop
severe in¯ammatory skin lesions de novo is not clear. One possible
explanation is that although the IL-4 expressed through attenuated
immunoglobulin promoter/enhancer altered the T cell population
towards a biased Th2 subtype, the limited exposure of T cells to
skin pathogens and perhaps also to allergens reduced the other
factors essential for the development of severe skin lesions. Placing
our skin-speci®c IL-4 Tg mice in both conventional and pathogen-
free facilities and observing the frequency and severity of their skin
lesion development may help to answer this question.
Four signal pathways involved in the initiation of Th2 immune
responses have been identi®ed, including IL-4, T cell receptor
ligation, IL-12Rb2 modulation, and IL-13 (Kopf et al, 1993;
MacKenzie et al, 1999). IL-4 and IL-13 are essential for the
synthesis of Th2-activated immunoglobulins IgG1 and IgE
(MacKenzie et al, 1999). Molecularly, IL-4 controls IgE synthesis
by providing the ®rst signal to the B cell's IL-4 receptor, in
conjunction with the second signal of interaction of CD40 and
CD40L, triggering the isotype switching (Oettgen and Geha,
1999). In our model, this Th2 enhancement occurs not only in an
organ-speci®c manner (evident by the development of pruritic
in¯ammatory skin disease, an organ-speci®c immune-mediated
disease), but also in a systemic manner (evident by the elevation of
total serum IgE and IgG1, apparently through a local expression of
IL-4) (Fig 4). This locally expressed IL-4 in the skin seems to be
essential for restricting this disease to the skin, as multiple-organ
expression of IL-4 induced systemic immune disorders (Erb et al,
1997). The concurrent elevation of total serum IgE and IgG1 and
the onset of skin lesions in our model suggest that IgE and IgG1
may be essential for the initiation of the skin lesions. Moreover, the
total serum IgE in the affected mice remained at high levels during
disease progression suggesting a role of IgE in the maintenance of
the disease. As not all affected mice have high titers of total serum
IgE, antigen-speci®c IgE may be a more speci®c assay in
determining the role of IgE in the pathogenesis of skin lesions.
Close to half of the Tg mice affected with skin in¯ammation
developed bacterial pyoderma, whereas none of the Tg mice
unaffected with skin in¯ammation developed any infection. The
cause-and-effect relationship between the cytokines and infection
in our model is not yet established. One hypothesis is that the
pruritus associated with the skin lesions leads to scratching and
excoriation, damaging the skin natural barrier and therefore
opening the door for bacterial infection. Supporting this hypothesis
is the observation that only those Tg mice affected with skin lesions
developed bacterial infection. The occurrence of bacterial pyo-
derma does not correlate with the extent of skin lesions, however
(Table I). Another hypothesis is that IL-4 expressed in the skin
downregulates the skin immune system in defense against a certain
type of pathogens, such as Staphylococcus aureus and Pseudomonas
aeruginosa, in such a way that even minor damage of the skin barrier
(as a result of a scratch) will allow severe infection to occur.
Observations from the studies of other skin infections lend some
support to this hypothesis (Yamamura et al, 1991; Heinzel and
Rerko, 1999). The presence of Th2 cytokine alone, however, does
not seem to account for the staphylococcal infection, as the
infection occurred only in those Tg mice affected with skin
in¯ammation. The availability of this new experimental mouse
model of pruritic in¯ammatory skin disease may facilitate the
investigation of the relationship between Th2 cytokine and skin
immunology in general and that between Th2 cytokine and
immune defense against infections in particular.
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